PATRICIA CARMEN MUÑOZ GARCÍA-rekin lankidetzan egindako argitalpenak (19)

2021

  1. Lymphocyte subsets early predict mortality in a large series of hospitalized COVID-19 patients in Spain

    Clinical and Experimental Immunology, Vol. 203, Núm. 3, pp. 424-432

  2. Secondary antibody deficiency is associated with development of infection in kidney transplantation: Results of a multicenter study

    Transplant Infectious Disease, Vol. 23, Núm. 2

2020

  1. Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 9, pp. 438-443

  2. Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 8, Núm. 10, pp. 3342-3347

  3. Preliminary Results of a Randomized Clinical Trial of Intravenous Immunoglobulin in Solid Organ Recipients with Severe Infection and Secondary Antibody Deficiency

    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, Vol. 39, Núm. 4, pp. S45-S46

2019

  1. Secondary Antibody Deficiency in a Heart Recipient with Systemic Aspergillosis

    OBM Transplantation, Vol. 3, Núm. 1

2018

  1. Infections in patients after Berlin Heart® EXCOR assist device implantation

    Transplant Infectious Disease, Vol. 20, Núm. 5

2016

  1. Early intravenous immunoglobulin replacement in hypogammaglobulinemic heart transplant recipients: results of a clinical trial

    Transplant Infectious Disease, Vol. 18, Núm. 6, pp. 832-843

2014

  1. Evaluation of an immunological score to assess the risk of severe infection in heart recipients

    Transplant Infectious Disease, Vol. 16, Núm. 5, pp. 802-812

2012

  1. Decreased levels of serum complement C3 and natural killer cells add to the predictive value of total immunoglobulin G for severe infection in heart transplant recipients

    Transplant Infectious Disease, Vol. 14, Núm. 5, pp. 526-539

  2. Restoration of humoral immunity after intravenous immunoglobulin replacement therapy in heart recipients with post-transplant antibody deficiency and severe infections

    Clinical Transplantation, Vol. 26, Núm. 3

  3. Simultaneous monitoring of cytomegalovirus-specific antibody and T-cell levels in seropositive heart transplant recipients

    Journal of Clinical Immunology, Vol. 32, Núm. 4, pp. 809-819

2009

  1. Prostatic Aspergillosis in a Heart Transplant Recipient: Case Report and Review

    Journal of Heart and Lung Transplantation, Vol. 28, Núm. 6, pp. 638-646

2007

  1. Clostridium difficile-associated Diarrhea in Heart Transplant Recipients: Is Hypogammaglobulinemia the Answer?

    Journal of Heart and Lung Transplantation, Vol. 26, Núm. 9, pp. 907-914

  2. The Potential Impact of Substitutive Therapy With Intravenous Immunoglobulin on the Outcome of Heart Transplant Recipients With Infections

    Transplantation Proceedings, Vol. 39, Núm. 7, pp. 2385-2388

2006

  1. IgG monitoring to identify the risk for development of infection in heart transplant recipients

    Transplant Infectious Disease, Vol. 8, Núm. 1, pp. 49-53

2005

  1. Decreased levels of serum immunoglobulins as a risk factor for infection after heart transplantation

    Transplantation Proceedings

  2. Hypogammaglobulinemia after heart transplantation: Use of intravenous immunoglobulin replacement therapy in relapsing CMV disease

    International Immunopharmacology, Vol. 5, Núm. 1, pp. 97-101

1997

  1. Ocular tuberculosis a prospective study in a general hospital

    Medicine, Vol. 76, Núm. 1, pp. 53-61